CADL 8-K: Shelf registration
Candel Therapeutics
Filed with the SEC on · accession 0001193125-26-458522
CADL filed a 8-K (current report) with the SEC on Nov 12, 2026. Candel Therapeutics entered into a new at-the-market (ATM) sales agreement with Jefferies LLC on November 12, 2026, allowing the company to sell up to $50 million of common stock.
Summary of the filing
Candel Therapeutics entered into a new at-the-market (ATM) sales agreement with Jefferies LLC on November 12, 2026, allowing the company to sell up to $50 million of common stock. This replaces a prior ATM agreement under which the full $50 million had already been sold.
Key details
✦ Ask GOAX AI about this filing — what it means for CADL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CADL?
Click hereFrequently asked questions
What did CADL file with the SEC on Nov 12, 2026?
CADL filed a 8-K (Shelf registration). Candel Therapeutics entered into a new at-the-market (ATM) sales agreement with Jefferies LLC on November 12, 2026, allowing the company to sell up to $50 million of common stock. This replaces a prior ATM agreement under which the full $50 million had already been sold.
What does a shelf registration mean for CADL stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other CADL SEC filings
- 8-K · Board changeSep 10, 2026
- 8-K · SEC filingSep 9, 2026
- 8-K · SEC filingAug 13, 2026
- 10-Q · SEC filingAug 13, 2026
- 144 · Insider sale plannedJun 29, 2026
- 144 · Insider sale plannedJun 29, 2026
- 8-K · Board changeJun 24, 2026
- 8-K · Executive departureJun 16, 2026
- 8-K · Fda approvalMay 15, 2026
- 10-Q · SEC filingMay 14, 2026
Get alerts when CADL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days